Emergency Briefing: “The Great Reset”
By May 28th, Americans could be faced with a difficult choice: Accept a "Great Reset" and risk losing the American way of life... or stand up and fight back to save what's left of the American dream. Jeff Brown, a member of a D.C.-based advocacy group, explains what every American must do before May 28th to preserve his assets and thrive.
Click here to see this emergency briefing before i

MIRM Insider Trading (Mirum Pharmaceuticals)

Insider Ownership Percentage: 45.50%
Insider Buying (Last 12 Months): $139,466.70
Insider Selling (Last 12 Months): $0.00

Mirum Pharmaceuticals Insider Trading History Chart

Mirum Pharmaceuticals Share Price & Price History

$18.20
▼ -0.95 (-4.96%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Man Who Predicted March 2020 Crash Says 2021 Is The Time
If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021...
Learn more here!

Mirum Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2020Christopher PeetzCEOBuy5,000$18.70$93,500.001,371  
12/23/2020Ian ClementsCFOBuy2,470$18.61$45,966.706,279  
3/19/2020Edwin Jonathan TuckerInsiderBuy2,000$9.91$19,820.003,500  
9/17/2019Laurent FischerDirectorBuy2,100$9.39$19,719.00
9/10/2019Laurent FischerDirectorBuy4,650$10.60$49,290.00
9/9/2019Christopher PeetzCEOBuy9,070$11.02$99,951.40
9/6/2019Ian ClementsSVPBuy4,000$11.51$46,040.00
9/6/2019Pamela VigInsiderBuy1,612$10.97$17,683.64
7/22/2019Holdings A/S NovoMajor ShareholderBuy575,000$15.00$8,625,000.00  
7/22/2019James E FlynnInsiderBuy332,000$15.00$4,980,000.00  
7/22/2019Patrick J HeronDirectorBuy450,000$15.00$6,750,000.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

72.90% of Mirum Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mirum Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/24/2021Alyeska Investment Group L.P.99,421$1.74M0.0%+98.9%0.387%
2/19/2021JPMorgan Chase & Co.2,331$41K0.0%-68.8%0.009%
2/18/2021Verition Fund Management LLC97,066$1.70M0.0%N/A0.377%
2/16/2021Squarepoint Ops LLC21,441$0.37M0.0%-9.4%0.083%
2/16/2021Alyeska Investment Group L.P.99,421$1.74M0.0%+98.9%0.387%
2/16/2021Baker BROS. Advisors LP647,313$11.30M0.0%+17.1%2.517%
2/16/2021Tudor Investment Corp Et Al25,000$0.44M0.0%N/A0.097%
2/16/2021Gyon Technologies Capital Management LP11,949$0.21M0.1%N/A0.046%
2/16/2021Charles Schwab Investment Management Inc.59,553$1.04M0.0%+1.8%0.232%
2/12/2021Caas Capital Management LP36,362$0.64M0.0%N/A0.141%
2/12/2021Laurion Capital Management LP41,800$0.73M0.0%N/A0.163%
2/12/2021Virtus ETF Advisers LLC12,292$0.22M0.1%-29.6%0.048%
2/11/2021Trexquant Investment LP13,734$0.24M0.0%N/A0.053%
2/11/2021Northern Trust Corp98,334$1.72M0.0%-2.6%0.382%
2/11/2021Steward Partners Investment Advisory LLC2,500$44K0.0%N/A0.010%
2/11/2021Monashee Investment Management LLC125,000$2.18M0.3%N/A0.486%
2/10/2021Renaissance Technologies LLC42,900$0.75M0.0%N/A0.167%
2/10/2021Panagora Asset Management Inc.21,169$0.37M0.0%N/A0.082%
2/9/2021Wells Fargo & Company MN19,038$0.33M0.0%+260.2%0.074%
2/9/2021Bank of New York Mellon Corp27,570$0.48M0.0%+41.9%0.107%
2/9/2021Chartwell Investment Partners LLC69,108$1.21M0.0%+51.9%0.269%
2/8/2021Alliancebernstein L.P.14,900$0.26M0.0%+11.2%0.058%
2/5/2021BlackRock Inc.554,889$9.69M0.0%+31.5%2.158%
2/4/2021GSA Capital Partners LLP21,709$0.38M0.1%N/A0.084%
12/14/2020Strs Ohio12,300$0.24M0.0%+1,657.1%0.048%
11/16/2020Chartwell Investment Partners LLC45,483$0.88M0.0%+165.8%0.179%
11/16/2020Squarepoint Ops LLC23,661$0.46M0.0%-15.5%0.093%
11/16/2020Worth Venture Partners LLC50,876$0.98M0.8%-4.3%0.200%
11/13/2020Morgan Stanley48,153$0.93M0.0%-52.8%0.190%
11/13/2020Charles Schwab Investment Management Inc.58,487$1.13M0.0%+281.4%0.230%
11/13/2020Virtus ETF Advisers LLC17,458$0.34M0.2%-12.0%0.069%
11/13/2020Sofinnova Investments Inc.321,252$6.19M0.5%-40.7%1.265%
11/13/2020AXA S.A.227,990$4.39M0.0%+36.5%0.898%
11/12/2020JPMorgan Chase & Co.7,480$0.15M0.0%+61.8%0.029%
11/10/2020State Street Corp102,803$1.98M0.0%+7.5%0.405%
11/6/2020BlackRock Inc.421,969$8.13M0.0%-0.8%1.661%
11/5/2020New York State Common Retirement Fund5,412$0.10M0.0%+73.9%0.021%
11/3/2020Lindbrook Capital LLC1,500$29K0.0%+200.0%0.006%
8/25/2020Nuveen Asset Management LLC10,396$0.20M0.0%N/A0.041%
8/20/2020Charles Schwab Investment Management Inc.15,333$0.30M0.0%+38.4%0.060%
8/14/2020Point72 Asset Management L.P.97,415$1.90M0.0%N/A0.384%
8/14/2020Bank of America Corp DE2,785$55K0.0%-30.9%0.011%
8/14/2020Worth Venture Partners LLC53,151$1.04M0.5%-1.4%0.209%
8/14/2020Alyeska Investment Group L.P.88,384$1.72M0.0%-39.3%0.348%
8/14/2020Driehaus Capital Management LLC90,000$1.75M0.0%N/A0.354%
8/14/2020Gyon Technologies Capital Management LP18,875$0.37M0.9%N/A0.074%
8/13/2020Sofinnova Investments Inc.541,701$10.54M0.7%+29.4%2.133%
8/12/2020Goldman Sachs Group Inc.30,940$0.60M0.0%-18.8%0.122%
8/12/2020Bank of New York Mellon Corp20,003$0.39M0.0%+16.8%0.079%
8/7/2020Trexquant Investment LP17,282$0.34M0.0%N/A0.068%
8/7/2020New York State Common Retirement Fund3,112$61K0.0%+93.1%0.012%
8/5/2020Virtus ETF Advisers LLC19,835$0.39M0.2%N/A0.078%
7/31/2020UBS Group AG15,797$0.31M0.0%-7.1%0.062%
7/29/2020Chartwell Investment Partners LLC17,110$0.33M0.0%N/A0.067%
6/19/2020State Street Corp50,228$0.70M0.0%+120.1%0.198%
6/15/2020AXA156,751$2.20M0.0%N/A0.617%
5/15/2020Squarepoint Ops LLC34,866$0.49M0.0%N/A0.137%
5/15/2020AXA156,751$2.20M0.0%N/A0.617%
5/15/2020Morgan Stanley3,422$48K0.0%-45.1%0.013%
5/15/2020Alyeska Investment Group L.P.145,711$2.04M0.0%+438.1%0.574%
5/15/2020Rock Springs Capital Management LP1,243,000$17.40M0.7%-0.2%4.896%
5/14/2020Wells Fargo & Company MN3,678$51K0.0%+1,465.1%0.014%
5/14/2020Geode Capital Management LLC93,358$1.31M0.0%+59.4%0.368%
5/13/2020EAM Global Investors LLC69,237$0.97M0.6%+14.4%0.273%
5/13/2020EAM Investors LLC53,832$0.75M0.2%+15.1%0.212%
5/13/2020Sofinnova Investments Inc.418,589$5.86M0.5%N/A1.649%
5/12/2020JPMorgan Chase & Co.8,264$0.12M0.0%+93.2%0.033%
5/11/2020Ensign Peak Advisors Inc1,853$26K0.0%-60.6%0.007%
5/11/2020State Street Corp50,228$0.70M0.0%+120.1%0.198%
5/6/2020Bank of New York Mellon Corp17,128$0.24M0.0%+48.8%0.067%
5/4/2020American International Group Inc.3,083$43K0.0%+83.1%0.012%
5/1/2020BlackRock Inc.256,735$3.59M0.0%+41.7%1.011%
5/1/2020UBS Group AG17,000$0.24M0.0%+252.9%0.067%
2/20/2020Geode Capital Management LLC58,568$1.44M0.0%+178.1%0.255%
2/17/2020Boxer Capital LLC317,000$7.77M0.4%N/A1.379%
2/14/2020Bank of New York Mellon Corp11,508$0.28M0.0%N/A0.050%
2/14/2020Marshall Wace North America L.P.1,011$25K0.0%N/A0.004%
2/14/2020Alyeska Investment Group L.P.27,080$0.66M0.0%-64.0%0.118%
2/14/2020UBS Group AG4,817$0.12M0.0%+34.3%0.021%
2/12/2020Raymond James & Associates8,843$0.22M0.0%N/A0.038%
2/11/2020EAM Investors LLC46,786$1.15M0.3%N/A0.204%
2/10/2020EAM Global Investors LLC60,509$1.48M0.6%N/A0.263%
2/6/2020Victory Capital Management Inc.2,024$32K0.0%N/A0.009%
2/6/2020State Street Corp22,819$0.56M0.0%+16.3%0.099%
2/5/2020New York State Common Retirement Fund1,612$40K0.0%-72.7%0.007%
2/4/2020Victory Capital Management Inc.2,024$32K0.0%N/A0.009%
1/27/2020Lindbrook Capital LLC2,000$49K0.0%N/A0.009%
11/27/2019Millennium Management LLC125,424$1.26M0.0%N/A0.546%
11/27/2019California State Teachers Retirement System4,191$42K0.0%N/A0.018%
11/27/2019State Street Corp19,616$0.20M0.0%N/A0.085%
11/5/2019Dean Capital Investments Management LLC45,420$0.46M0.3%N/A0.198%
Data available starting January 2016

See Full Table
Mirum Pharmaceuticals logo
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its lead product candidate is maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. The company is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was founded in 2018 and is headquartered in Foster City, California.
Read More

Today's Range

Now: $18.20
$18.10
$19.28

50 Day Range

MA: $19.09
$16.29
$20.60

52 Week Range

Now: $18.20
$13.60
$27.43

Volume

48,386 shs

Average Volume

148,594 shs

Market Capitalization

$553.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.44

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?

Mirum Pharmaceuticals' top insider investors include:
  1. Ian Clements (CFO)
  2. Edwin Jonathan Tucker (Insider)
  3. Christopher Peetz (CEO)
  4. Holdings A/S Novo (Major Shareholder)
  5. Ian Clements (SVP)
  6. James E Flynn (Insider)
  7. Laurent Fischer (Director)
  8. Pamela Vig (Insider)
  9. Patrick J Heron (Director)
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel